Logo ofJamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma)
Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) announced its intention to disclose its financial results for the third quarter of 2025 before the opening of trading on the Saudi Stock Exchange on Oct. 23. 
According to a statement to Tadawul, the company pointed out that it will hold a conference call at 3:00 PM (KSA time) on the same day to discuss the financial results with investors and analysts.
According to data available on Argaam, analysts expect Jamjoom Pharma to post a net profit of SAR 115.18 million in Q3 2025.
Logo ofJamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma)
Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) announced its intention to disclose its financial results for the third quarter of 2025 before the opening of trading on the Saudi Stock Exchange on Oct. 23.
According to a statement to Tadawul, the company pointed out that it will hold a conference call at 3:00 PM (KSA time) on the same day to discuss the financial results with investors and analysts.
According to data available on Argaam, analysts expect Jamjoom Pharma to post a net profit of SAR 115.18 million in Q3 2025.
